Haixi Pharmaceuticals (02637.HK) proposes appointing Rong Cheng as the company's auditor.

Zhixin Finance APP News, Sinopharm Healthcare (02637.HK) announced that the company held a board of directors audit committee meeting on July 9, 2026 to recommend changing accounting standards and corresponding audit firm. On July 15, 2026, after considering the audit committee's recommendation, the board of directors decided to propose a resolution to adopt Chinese Accounting Standards to prepare financial reports uniformly, recommend terminating the engagement of Deloitte, and appoint RSM Hong Kong (a special general partnership) as the company's external auditor for the fiscal year ending December 31, 2026, serving until the end of the next annual shareholders' meeting.